Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Milestone Pharmaceuticals Inc. - Common Shares (NQ: MIST )

1.170 +0.010 (+0.86%)
Streaming Delayed Price Updated: 12:31 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 929,074
Open 1.170
Bid (Size) 1.160 (35)
Ask (Size) 1.170 (15)
Prev. Close 1.160
Today's Range 1.090 - 1.179
52wk Range 0.6254 - 2.499
Shares Outstanding 53,353,984
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session.
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Top movers in Friday's session
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill

Performance

YTD
-46.08%
-46.08%
1 Month
-42.93%
-42.93%
3 Month
-41.21%
-41.21%
6 Month
-20.41%
-20.41%
1 Year
-31.18%
-31.18%

More News

Read More
Milestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst Nasal Spray – But Retail’s Positive
Via Stocktwits
Exposures Product Safety
Milestone Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
Why Milestone Pharmaceuticals (MIST) Stock Is Rising
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Traders are paying attention to the gapping stocks in Friday's session.
Via Chartmill
Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Top movers in Friday's pre-market session
Via Chartmill
Why Is Milestone Pharmaceuticals Stock Plunging Today?
Via Benzinga
Exposures Product Safety
Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected
Via Benzinga
Topics Economy
Exposures Interest Rates
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q2 2024
Via InvestorPlace
MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q1 2024
Via InvestorPlace
MIST Stock Earnings: Milestone Pharmaceuticals Misses EPS for Q4 2023
Via InvestorPlace
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
MILESTONE ALERT: Bragar Eagel & Squire, P.C. is Investigating Milestone Pharmaceuticals Inc. on Behalf of Milestone Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – MIST
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Milestone Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - MIST
Via NewMediaWire
Exposures Product Safety
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.